期刊文献+

激素替代疗法的用药分析 被引量:3

Analyzing Amount of the Medicines for Hormone Replacement Therapy
暂未订购
导出
摘要 目的 分析激素替代治疗(hormone replacement therapy therapy,HRT)药物在浙江大学医学院附属妇产科医院(浙医妇院)的用药情况,了解其与人们对生命质量的重视程度与经济能力的关系。方法 收集了浙医妇院1997—2001年HRT用药,进行纵向比较,并与同时期杭州地区的用药作横向比较以及医保前后的用药比较。采用趋势检验与卡方检验。结果 1997—2001年浙医妇院的HRT用药量的格局有显著变化,尼尔雌醇片的用量均呈逐年减少(P<0.01),而补佳乐片的用量逐年增多(P<0.01),倍美力片的用量在1998年较1997年有显著增加(P<0.01),以后用量趋于平稳;杭州地区的尼尔雌醇片用量显著高于浙医妇院,而补佳乐片和倍美力片的用量显著低于浙医妇院;医保前后各类HRT用药无显著变化。结论 HRT用药发生显著变化,其主要影响因素是人们对生命质量的重视程度与经济能力。 OBJECTIVE The aim of this study is to analyze amount of the medicines for hormone replacement therapy (HRT) in Affiliated women hospital Zhejiang University. METHODS The data of amount of the medicines for HRT from 1997 to 2001 in the women hospital were collected. Longitudinal and transverse comparisons were done to determine the changes of the amount. The tendency test and chi-square test were used. RESULTS The amount of the medicines for HRT in the hospital changed significantly.The amount of nilestriol tablets decreasenwhile that of Progynova and Conjugated Estrogens Tablets increased ( P < 0.01) .The amount of nilestriol tablets in the women hospital was much more than that in Hangzhou orea( P < 0.01). There were no changes in amount of the medicines for HRT between before medical insurance reform and after that. CONCLUSION The amount of the medicines for HRT has changed greatly, which was mainly due to the shift of attitudes to quality of life and economic level of the people.
出处 《中国初级卫生保健》 2002年第9期52-54,共3页 Chinese Primary Health Care
关键词 激素替代治疗 用药分析 尼尔雌醇片 hormone replacement therapy(HRT), medicine amounti analysis
  • 相关文献

参考文献1

二级参考文献14

  • 1Shaw RW.Oestrogen Deficiency.UK:The parthenon publishing Group,1996,45~116.
  • 2Hui SL.Age and bone mass as predictors of fracture in a prospec-tive study.J Clin Invest,1988,81:1804.
  • 3Matkovic V,Jelic T,Wardlaw GM,et al.Timing of peak bone mass in caucasian females and its implication for the prevention of osteo-porosis.J Clin Invest,1994,93:799.
  • 4Ott SM.Attainment of peak bone mass.J Clin Endocrinol Metab,1990,71:1082A.
  • 5Clen TL.Glucocorticoid receptors and inhibition of bone cell growth in primary culture.J Endocrinol,1977,100:619.
  • 6Prior JC,Vigna YM,Schechter MT,Burgess AE.Spinal bone loss and ovulatory disturbances.N Engl J Med,1990,323(18):1221.
  • 7Ettinger B.Long-term estorgen replacement therapy prevents bone loss and fractures.Am Intern Med,1985,102:319.
  • 8Abdalla HI,Mckay HD,Lindsay R,et al.Prevention of bone mineral loss in postmenopausal women by norethisterone.Obstet Gynecol,1985,66(6):789.
  • 9Naessen T,Olsson SE,Gudmundson J.Differential effects on bone density of progestogen-only methods for contraception in pre-menopausal Women,1995,52:23.
  • 10Cromer BA.Blair JM,Mahan JD,et al.A prospective comparison of bone density in adolescent girls receiving depot medroxypro-gest-erone acetaie,levonorgestrel,or oral contraceptives.J Pedi-atr,1996,129(5):671.

共引文献8

同被引文献54

引证文献3

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部